Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 2
1988 3
1989 9
1990 4
1991 3
1992 1
1993 4
1994 1
1995 5
1996 5
1997 5
1998 7
1999 3
2000 6
2001 5
2002 6
2003 2
2004 1
2005 2
2006 2
2007 1
2009 2
2012 1
2015 1
2016 1
2018 1
2019 2
2020 3
2021 5
2022 2
2023 2
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

96 results

Results by year

Filters applied: . Clear all
Page 1
Risk-Adapted Neoadjuvant Chemoradiotherapy in Rectal Cancer: Final Report of the OCUM Study.
Ruppert R, Junginger T, Kube R, Strassburg J, Lewin A, Baral J, Maurer CA, Sauer J, Lauscher J, Winde G, Thomasmeyer R, Stelzner S, Bambauer C, Scheunemann S, Faedrich A, Wollschlaeger D, Merkel S. Ruppert R, et al. Among authors: winde g. J Clin Oncol. 2023 Aug 20;41(24):4025-4034. doi: 10.1200/JCO.22.02166. Epub 2023 Jun 19. J Clin Oncol. 2023. PMID: 37335957
Sulindac sulfide inhibits Ras signaling.
Herrmann C, Block C, Geisen C, Haas K, Weber C, Winde G, Möröy T, Müller O. Herrmann C, et al. Among authors: winde g. Oncogene. 1998 Oct 8;17(14):1769-76. doi: 10.1038/sj.onc.1202085. Oncogene. 1998. PMID: 9778042
Selection of patients with rectal cancer for neoadjuvant therapy using pre-therapeutic MRI - Results from OCUM trial.
Stelzner S, Ruppert R, Kube R, Strassburg J, Lewin A, Baral J, Maurer CA, Sauer J, Lauscher J, Winde G, Thomasmeyer R, Bambauer C, Scheunemann S, Faedrich A, Wollschlaeger D, Junginger T, Merkel S. Stelzner S, et al. Among authors: winde g. Eur J Radiol. 2022 Feb;147:110113. doi: 10.1016/j.ejrad.2021.110113. Epub 2021 Dec 28. Eur J Radiol. 2022. PMID: 35026621
New indene-derivatives with anti-proliferative properties.
Karaguni IM, Glüsenkamp KH, Langerak A, Geisen C, Ullrich V, Winde G, Möröy T, Müller O. Karaguni IM, et al. Among authors: winde g. Bioorg Med Chem Lett. 2002 Feb 25;12(4):709-13. doi: 10.1016/s0960-894x(01)00839-3. Bioorg Med Chem Lett. 2002. PMID: 11844707
96 results